Uvax Bio
Newark, DE, United States · uvaxbio.com
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Uvax Bio develops vaccine candidates using its proprietary 1c-SA p NP® nanoparticle platform. It works on rational antigen design and protein engineering for infectious diseases, including an HIV-1 vaccine program. The company is based in the United States, with contact information provided through its website.
They take quote requests by email.
What they offer
Vaccine candidate design
Designs vaccine constructs using rational antigen design and structure-based approaches.
Protein nanoparticle vaccine platform development
Develops vaccines on a proprietary 1c-SA p NP® protein nanoparticle display platform.
Virus-like particle vaccine development
Creates virus-like particle vaccines intended to elicit protective immune responses against infectious diseases.
Preclinical vaccine development
Advances vaccine assets through preclinical development for infectious disease programs.
What they work on
- Modalities
- Vaccine
- Scale and capacity
- 45-70 nm nanoparticles, 20 stabilized trimers or 60 monomers displayed on the surface
- Therapeutic areas
- infectious diseases, HIV-1
- Founded
- 2018
Similar labs. 2TLab, 3C Therapeutics, 53Biologics, 64x
Found in a contract services directory. Listing built from uvaxbio.com. Work here? Claim this listing.